pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Delivery of piperlongumine via hyaluronic acid/phenylboronic acid-mediated dual targetable polymersome for enhanced anticancer functionality against tumor Beyond the tumor: Enhancing pancreatic

Name: pancreatic cancer glutathione enhancement Delivery of piperlongumine via hyaluronic acid/phenylboronic acid-mediated dual targetable polymersome for enhanced anticancer functionality against tumor Beyond the tumor: Enhancing pancreatic
Brand: crisbcreativa.com
SKU: 91168707682
Price: 23.85 USD
Availability: InStock
Rating: 4.1116 (5 reviews)

Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery Su 2025 Journal of Cell Communication and Signaling Wiley Online Library Glutathione metabolism is essential for self renewal and chemoresistance of pancreatic cancer stem cells PMC Frontiers Integrated Analysis of Glutathione Metabolic Pathway in Pancreatic Cancer Frontiers Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives Increased glucose availability sensitizes pancreatic cancer to chemotherapy bioRxiv

SKU: 91168707682 · From crisbcreativa.com

4.1

USD23.85 USD60.85

Pay in 4 interest-free payments of $5.96 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 18 - Sep 23

Description

Vitamin D (D) Regulates reproductive hormones and supports immune toleranceimportant for implantation

Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure

[CrossRef] [Google Scholar] Seeing is believing: engineering anthocyanin and carotenoid biosynthetic pathways

2290-C CONCOMITANT OBESOGENIC DIET AND ALCOHOL INDUCE A PRO-INFLAMMATORY ENVIRONMENT WITHOUT HISTOLOGIC STEATOHEPATITIS IN MICE Joseph L Dempsey 1 , Delfin Buyco 2 , Joe Lim 1 , Sina A

In breast cancer, the expression of miR-33a-5p was significantly decreased compared to the normal tissue, and the decreased expression of miR-33a-5p was correlated with poor survival of a patient with breast cancer